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Tsc1 represses parvalbumin expression and fast-
spiking properties in somatostatin lineage cortical
interneurons
Ruchi Malik 1,2,3, Emily Ling-Lin Pai1,4,5, Anna N Rubin 1,5, April M Stafford6, Kartik Angara6, Petros Minasi1,
John L. Rubenstein1,4,5, Vikaas S Sohal1,2,3* & Daniel Vogt 6,7*
Medial ganglionic eminence (MGE)-derived somatostatin (SST)+ and parvalbumin (PV)+
cortical interneurons (CINs), have characteristic molecular, anatomical and physiological
properties. However, mechanisms regulating their diversity remain poorly understood. Here,
we show that conditional loss of the Tuberous Sclerosis Complex (TSC) gene, Tsc1, which
inhibits the mammalian target of rapamycin (MTOR), causes a subset of SST+ CINs, to
express PV and adopt fast-spiking (FS) properties, characteristic of PV+ CINs. Milder
intermediate phenotypes also occur when only one allele of Tsc1 is deleted. Notably, treat-
ment of adult mice with rapamycin, which inhibits MTOR, reverses the phenotypes. These
data reveal novel functions of MTOR signaling in regulating PV expression and FS properties,
which may contribute to TSC neuropsychiatric symptoms. Moreover, they suggest that CINs
can exhibit properties intermediate between those classically associated with PV+ or SST+
CINs, which may be dynamically regulated by the MTOR signaling.
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Tuberous sclerosis complex (TSC) is a disorder that affectsmultiple organ systems. Roughly half of those diagnosedwith TSC have autism spectrum disorder (ASD) or intel-
lectual disability (ID), and ~90% exhibit seizures1–4. TSC is
caused by mutations in the TSC1 and TSC2 genes, which encode
the HAMARTIN and TUBERIN proteins, respectively5,6.
HAMARTIN and TUBERIN proteins dimerize to form a protein
complex that inhibits the activity of the mammalian target of
rapamycin (MTOR), a protein complex that is a rheostat for
energy homeostasis and is also an important regulator of protein
translation7. Multiple proteins in the TSC/MTOR signaling
pathway are either high confidence ASD-causative genes or
underlie disorders with high ASD coincidence8,9. This has rele-
vance to the high rate of ASD in TSC and potentially other TSC-
Associated Neuropsychiatric Disorders (TANDs), which are
common in the syndrome10. Uncovering how this pathway reg-
ulates neuronal development and function is, therefore, funda-
mental to understanding the molecular and cellular
underpinnings of ASD and complex neuropsychiatric symptoms
in TSC.
Accumulating evidence suggests that neuropsychiatric dis-
orders, such as ASD, and associated comorbidities like epilepsy,
may be partially caused by changes in cortical GABAergic
interneuron (CIN) function and connectivity, which leads to
excitation/inhibition (E/I) imbalance in cortical circuits11. While
the role of MTOR signaling and Tsc genes on excitatory neurons
has been studied for some time, relatively little is known about
their roles in CIN development and function12–14. CINs are the
major source of cortical inhibition and are largely derived
from the medial and caudal ganglionic eminences (MGE and
CGE)15,16. Parvalbumin (PV)+ and somatostatin (SST)+ CINs
are derived from MGE and constitute ~70% of all CINs. These
cells have substantially different morphological and physiological
properties17,18. PV+ CINs exhibit fast-spiking (FS) firing prop-
erties and synapse onto soma/axons of excitatory neurons. By
contrast, SST+ CINs have regular-spiking (RS) firing properties
and target the distal dendrites of excitatory neurons18,19. The
difference in firing properties between SST+ and PV+ CINs is
dependent on the differential expression of voltage-gated ion
channels. Specifically, expression of delayed rectifying potassium
channels (Kv3) is critical for FS physiology of PV+ CINs20.
From their birth through maturity, CINs acquire a combina-
tion of molecular, cellular and physiological characteristics (hence
referred to as cell programming). Most studies investigating
MGE-derived CIN programming have largely focused on the role
of transcription factors (TFs)21–24, yet little is known about how
cellular signaling influences CIN development. Recent work from
us and others highlighted the importance of Pten, another inhi-
bitor of MTOR signaling that acts upstream of Tsc1, on estab-
lishing proper numbers of MGE-derived CINs in the cortex25,26.
Therefore, we speculate that aberrant MTOR signaling in TSC
might lead to abnormalities in the development and function of
MGE-derived CINs.
To investigate this, we conditionally deleted Tsc1 in MGE-
derived SST-lineage CINs, which allowed us to assess the impact
of Tsc1 loss/MTOR activity starting during early post-mitotic
stages. We then investigated the role of Tsc1/MTOR signaling in
CIN cell programming. Surprisingly, homozygous loss of Tsc1
caused SST-lineage CINs to aberrantly exhibit properties of
PV+/FS CINs. In addition, this phenotype can be rescued by
inhibiting MTOR during adult stages, suggesting that drugs
currently being studied to treat TSC, including rapamycin deri-
vatives, may be effective in treating TSC symptoms caused by
CIN dysfunction. Overall, our findings demonstrate novel roles
for Tsc1 in the development and function of CINs. We propose
that the choice between SST+ and PV+ cell programming is
mediated in part by non-transcriptional processes, including
cellular signaling events, suggesting a new avenue towards
understanding these important cell types.
Results
Loss of Tsc1 causes ectopic PV expression in SST lineages. To
test whether loss of Tsc1 in SST-expressing post-mitotic CINs
alters their development, we crossed Tsc1floxed mice27 and SST-
IRES-Cre mice28 (SST-Cre hereafter). The Cre-dependent tdTo-
mato reporter, Ai1429, was included to track the Tsc1 WT, con-
ditional heterozygous (cHet) and knockout (cKO) cells. Tsc1
transcript was absent from SST-Cre; Tsc1 cKO CINs in the
neocortex at postnatal day (P) 35 (Supplementary Fig. 1a–d). At
the same age, SST-Cre-lineage cHet and cKO cells in the neo-
cortex had elevated levels of ribosomal subunit S6 phosphorylated
at Serines 240 and 244 (Supplementary Fig. 1e-g), indicating
increased MTOR activity. Tsc1 cKOs had normal numbers of
SST-Cre-lineage CINs (tdTomato+) in the neocortex but the cells
had increased soma size (Fig. 1a–h). The laminar distribution of
tdTomato+ CINs was not altered by Tsc1 deletion (Supplemen-
tary Fig. 2).
SST-lineage CINs are derived from MGE progenitors that also
give rise to PV+ CINs. Thus, we investigated the expression of
SST and PV at P35 in the neocortex. While the % of tdTomato+
CINs that expressed SST was unchanged, there was ~3-fold
increase in the % of SST-Cre-lineage CINs that expressed PV in
cKO mice (Fig. 1a–f, i, j). These data suggest that SST and PV
proteins could be co-expressed in a subset of SST-Cre-lineage
CINs in cKO mice. To test this, we quantified WT, Tsc1 cHet and
cKO neocortices for SST and PV co-labeled CINs at P35 in the
neocortex. While there were almost no co-labeled CINs in WTs,
~2 and 13% co-labeled CINs were observed in cHets and cKOs,
respectively (Fig. 1k–q). A similar phenotype of ectopic PV
expression in SST+ CINs after Tsc1 deletion was observed in
Nkx2.1-Cre; Tsc1 cKOs (Supplementary Fig. 3), which begins to
express in MGE progenitors30. Together, these data suggest that
Tsc1 deletion causes PV expression in a subset of SST-lineage
CINs, and its deletion causes these SST+ CINs to develop a dual
molecular identity.
Since PV expression was elevated in a subset of SST+ CINs
after Tsc1 deletion, we wanted to assess whether MTOR activity
may be different in WT SST+ and WT PV+ CINs in the
neocortex. To this end, we assessed the expression of phosphory-
lated S6, a marker of MTOR activity, in SST+ or PV+ CINs in
the P35 WT neocortex. While only ~20% of SST+ CINs co-
expressed this marker, ~70% of PV+ CINs were co-labeled
(Fig. 2a–g). Thus, PV+ CINs normally exhibit greater MTOR
activity than SST+ CINs in the neocortex.
SST CINs in Tsc1 cKOs exhibit fast-spiking properties. Next,
we assessed the physiological properties of SST-lineage CINs in
the Tsc1 cKOs. We obtained ex vivo patch clamp recordings from
layer 5 SST-Cre-lineage CINs (tdTomato+) in WT, cHet and
cKO mice (example cells, Fig. 3a, and current induced voltage
responses, Fig. 3b). WT CINs had RS physiological properties,
including strong spike frequency accommodation (SFA), wider
spikes, relatively slow action potential (AP) rate of rise (max dV/
dt) and relatively small fast afterhyperpolarization (fAHP)
amplitudes (Fig. 3), as expected17,18,31. Consistent with the
increased complexity of neuron processes promoted by increased
MTOR signaling31,32, loss of Tsc1 decreased the input resistance
(Rin) and produced a corresponding increase in the rheobase
(current threshold) of cKO CINs (Fig. 3c, f). A reduction in Rin
and an increase in rheobase predicts that Tsc1 loss would lower
the excitability of SST+ CINs. However, Tsc1 cKO CINs had
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increased firing output (Fig. 3d, g–h). This increase was most
pronounced within a subset of SST-Cre lineage CINs that shifted
their physiology from RS to FS (Fig. 3h and Supplementary
Fig. 4). This shift from a RS to FS phenotype was most prevalent
in CINs from cKO mice (Fig. 3g, h), and was consistent with the
increased % of tdTomato+ CINs expressing PV (Fig. 1). Most of
the SST-lineage CINs classified as FS in Tsc1 cKOs expressed PV
(Supplementary Fig. 5). While a small subset of CINs in cHet and
cKO mice completely switched their physiology from RS to FS,
~30%; the firing and single AP properties of most SST-Cre-lineage
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Fig. 1 Post-mitotic deletion of Tsc1 in SST-Cre-lineages results in increased PV expression. Coronal immunofluorescent images from WT, Tsc1 cHets or Tsc1
cKOs P35 neocortices, showing co-localization of tdTomato (SST-Cre-lineages) with either SST (a–c) or PV (d–f). Arrows d–f denote cells in the SST-Cre-
lineage that express PV. g Quantification of the number of tdTomato+ cells/mm2 (cell density) in the neocortex: n= 6 (WT), 6 (cHet) and 4 (cKO) mice,
One-way ANOVA (F2, 13= 0.35, P= 0.7). h Quantification of tdTomato+ cell soma size: n= 4 mice per genotype (100 cells measured from each
genotype), (F2, 297= 44.9, P < 0.0001; cKO vs. WT and cHet, p < 0.0001). (AU) arbitrary units. g, h Quantification of the %tdTomato+ cells that co-
express either SST (i) or PV (j): Chi-squared test with Yate’s correction, (p < 0.0001, all groups); n= 6 WT (1268 cells), n= 6 cHet (1371 cells) and n= 4
cKO (1218 cells) for SST; n= 5 WT (1281 cells), n= 6 cHet (1600 cells) and n= 4 cKO (1220 cells) for PV. k–p Immunofluorescent images showing SST
and PV co-labeling in the neocortex. q Quantification of the %SST+ CINs that co-express PV: Chi-squared test with Yate’s correction, (WT vs. cHet,
p= 0.03, cKO vs. WT or cHet, p < 0.0001), n= 3 mice, all groups. Data are represented as mean ± SD in (h) and ± SEM in all other graphs. Scale bars in
f, p= 100 µm. *p < 0.05, ****p < 0.0001. Source data are provided as a Source Data file
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CINs in cHet and cKO mice shifted towards a FS-like physiology.
Further, the firing output and AP properties of SST+ CINs with
FS physiology were comparable to properties of FS PV+ CINs
(Supplementary Fig. 6). Significant shifts were observed in AP
threshold, AP rate of rise (max. dV/dt), AP duration and fAHP
amplitudes (Fig. 3i–m).
Apart from differences in firing properties, SST+ and PV+ CINs
are known to differ in their expression of Hyperpolarization-
activated cyclic nucleotide-gated (HCN) channels33. Compared to
WT SST+ CINs, WT PV+ CINs have lower HCN channel
mediated sag and rebound. However, the Tsc1 deletion mediated
switch in physiology of SST+ CINs was not accompanied by a
change in sag and rebound (Supplementary Fig. 7). Together,
these analyses showed that while loss of Tsc1 reduced the
excitability of SST+ CINs, their overall firing output was higher
due to the increased proportion of SST+ CINs with PV-like/FS
properties.
Increased Kv3.1 expression in Tsc1 cKO SST CINs. Since Tsc1
deletion resulted in a shift towards FS physiology within SST-Cre-
lineages, we asked whether Tsc1 cHets and cKOs had increased
levels of the fast-inactivating Kv3.1 potassium channel. Kv3.1
expression is primarily restricted to PV+ CINs and is the primary
contributor to their fast-spiking properties (like short AP half-
width and large fAHP)20,34 (Supplementary Fig. 8). Indeed, we
found that a similar proportion of SST-Cre-lineage CINs co-
expressed Kv3.1 in cHets and cKOs (Fig. 4a, b).
To understand the effects of increased Kv3.1 channel
expression on the physiological properties of SST+ CINs, we
used biophysical simulations in four different models of
neocortical layer 5 SST+ CINs35. Specifically, we asked if an
increase in somatic Kv3.1 conductance density was sufficient to
produce a transition from RS to FS properties (similar to the
switch observed in Tsc1 cKOs). In all four models, increasing
Kv3.1 conductance density increased the firing output (~28%),
reduced spike frequency accommodation (~40%), reduced AP
half-width (~32%), and increased fAHP amplitude, (~80%)
(Fig. 4c–i and Supplementary Fig. 9). These results suggest that
the FS properties observed in Tsc1 cKOs are due to elevated
Kv3.1channels in SST-lineage CINs.
Tsc1 deletion caused an increase in pS6, PV and Kv3.1
expression in a cohort of SST-Cre-lineage CINs, and also
increased their cell body (soma) size. Since SST-Cre-lineage
CIN cKOs exhibited a range of soma sizes, it allowed us to assess
whether cell size was correlated with the increased expression of
molecular markers, i.e. pS6, PV and Kv3.1. We found a positive
correlation between cell size and pS6 expression but no
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Fig. 2 The MTOR activity marker, pS6, is preferentially enriched in PV+ CINs. a–c P35 immunofluorescent images of WT neocortices co-labeled for SST
and pS6. d–f Immunofluorescent co-labeling of PV and pS6 from P35 WT neocortices. Arrows denote co-labeled CINs. g Quantification of the % of either
SST+ or PV+ CINs that are pS6+: Chi-squared test with Yate’s correction, ****p < 0.0001. Data are expressed as the ± SEM, n= 3 mice/marker (145
SST cells and 208 PV cells counted). Scale bar in f= 100 µm. Source data are provided as a Source Data file
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correlation between increased cell size and the expression of PV
or Kv3.1, suggesting that cell size per se may not lead to the
elevated PV and Kv3.1 levels (Supplementary Fig. 10).
Reduced inhibitory synaptic output in Tsc1 cKOs. Given that
loss of Tsc1 affected the excitability and firing output of SST+
CINs, we wondered how these changes might affect inhibitory
synaptic output onto nearby pyramidal neurons. Thus, we com-
pared spontaneous inhibitory postsynaptic currents (sIPSCs)
recorded from cortical layer 5 pyramidal neurons in WT, cHet
and cKO mice (Fig. 5a). Surprisingly, the frequency and
amplitude of sIPSCs was lower in cHet and cKO mice (Fig. 5c).
We had expected that the increase in firing output might result in
increased spontaneous inhibitory transmission. This reduction
in spontaneous inhibitory output could be caused by a reduction
in numbers of inhibitory synapses and/or probability of release at
these synapses. Towards elucidating the respective contributions
of these various possibilities, we added TTX (1 µM) to the
recording solution, to remove large amplitude, AP-dependent
IPSCs (and therefore any effects of changes in excitability).
Similar to sIPSCs, the frequency and amplitude of miniature
IPSCs (mIPSCs) were lower in Tsc1 cKOs (Fig. 5b, d). There were
no changes in sIPSC and mIPSC rise time and tau between
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genotypes (Supplementary Fig. 11a–d). These findings suggested
that the loss of Tsc1 reduced the strength of inhibitory synaptic
transmission by altering the number and/or release probability at
inhibitory synapses.
While we found significant reductions in spontaneous
inhibitory output to cortical pyramidal neurons, we could not
estimate the specific contribution of SST+ CINs to this reduction
by analyzing sIPSCs and mIPSCs. To directly address this, we
expressed ChR2-eYFP in SST-Cre lineage CINs (WT, cHet and
cKO). By delivering pulses of blue (470 nm) light, during voltage-
clamp recordings, we measured optogenetically-evoked IPSCs
(oIPSCs) from SST-lineage CINs onto layer 5 pyramidal neurons
(Fig. 5e, f). In line with the observed reduction in spontaneous
inhibitory output, oIPSCs were also significantly smaller in Tsc1
cKOs (Fig. 5g); oIPSC rising slope was not altered but an increase
was observed in decay tau in cHets (Supplementary Fig. 11e, f).
To measure the presynaptic release probability, we measured the
frequency-dependent attenuation of oIPSCs and paired-pulse
ratio (PPR). The attenuation of oIPSCs in response to 20 Hz light
pulses was significantly lower in cKOs (Fig. 5h, i). Furthermore,
cKOs had significantly higher paired-pulse ratios (PPRs) (Fig. 5j).
These results suggest that Tsc1 deletion decreases the evoked
inhibitory output at least in part by reducing presynaptic release
probability in SST-lineage CINs.
The axons of PV+/FS CINs target the soma and axon initial
segment of pyramidal neurons, while the axons of SST+ CINs
target their distal dendrites18,19. Thus, we tested whether Tsc1
deletion caused aberrant axon targeting (proximal dendrite/soma
vs. distal dendrite) in a subset of SST-lineage CINs. For this, we
obtained paired patch clamp recordings from connected layer 5
pyramidal neurons (Pyr) and tdTomato+ SST-Cre-lineage CINs
(Fig. 6a) and analyzed the unitary IPSCs (uIPSCs) in postsynaptic
Pyr neurons evoked by action potentials in presynaptic SST+
CINs (Fig. 6b). Since uIPSCs generated in response to SST+ CINs
arrive at the distal dendrites, the amplitude and kinetics of these
currents are significantly different from IPSCs originating near
the soma of pyramidal neurons36. To validate this, we compared
the properties of CIN→ Pyr uIPSCs in PV-Cre-lineage37 CIN-
pyramidal neuron vs. SST-Cre-lineage CIN-pyramidal neuron
pairs. In our recordings from WT mice, all PV-Cre lineage CINs
had FS physiology and all SST-Cre lineage CINs had RS
physiology (Fig. 6c). A comparison of the kinetics of SST→ Pyr
uIPSCs and PV→ Pyr uIPSCs in WT mice showed that the
uIPSC amplitude, rising slope, and total charge were all
significantly larger for PV→ Pyr pairs than SST→ Pyr pairs
(Fig. 6d–f). Next, we recorded SST→ Pyr uIPSCs in cKO mice.
As expected, most SST-Cre-lineage CINs in cKOs had RS
properties but a subset had FS properties (Fig. 6c). Strikingly,
in our paired recordings from cKOs, the amplitude, kinetics and
total charge uIPSCs did not differ for RS/SST→ Pyr vs. FS/
SST→ Pyr pairs (Fig. 6d–f). These results suggest that while Tsc1
deletion caused a switch in physiological properties and
molecular identity of SST-Cre lineage CINs towards a PV-like/
FS physiology, it did not affect their axonal targeting. Notably,
morphological reconstructions of SST+ CIN axons showed that
loss of Tsc1 was not accompanied by changes in axonal targeting
and branching (Supplementary Fig. 4). These findings, together
with the lower presynaptic release probability, may explain why,
despite the increased firing output and shift towards PV-like
phenotypes, inhibitory output mediated by SST+ CINs is reduced
in Tsc1 cKOs.
Cell autonomous role for Tsc1 in PV CINs. Since Tsc1 cKOs
exhibited reduced inhibitory tone in the neocortex (Fig. 5), we
asked if the increased PV expression in SST-Cre-lineages is cell
autonomous, as PV expression can be modulated by circuit
activity38,39. We utilized an MGE transplantation assay that
introduces MGE progenitors in small numbers to a WT cortex for
in vivo maturation40. MGE tissue from WT, Tsc1Floxed/+ or
Tsc1Floxed/Floxed was isolated from E13.5 embryos; dissociated
cells were transduced with DlxI12b-Cre expressing lentiviruses
(Fig. 7a). The DlxI12b enhancer biases expression to GABAergic
neurons and has been used to express genes efficiently in devel-
oping and mature CINs25,41,42. These MGE cells were then
transplanted into WT neonatal cortex and allowed to develop.
After 35 days post-transplant (DPT), we assessed the proportion
of transplanted cells (tdTomato+) that expressed PV. Tsc1 cKO
cells had increased soma size and ~2-fold increase in PV
expression compared to WT (Fig. 7b–d, f, g). Finally, we
expressed the human TSC1 gene from the same lentiviral vector,
to test if human TSC1 could compliment the mouse Tsc1 depleted
CINs and found that it was able to rescue the increase in soma
size and PV expression (Fig. 7e–g).
Rapamycin decreases PV and FS properties in Tsc1 cKOs. We
hypothesized that Tsc1 normally represses PV-like/FS properties
in SST+ CINs by inhibiting MTOR activity. We thus adminis-
tered the MTOR inhibitor, rapamycin, to test whether this
treatment might reverse/rescue the effects of Tsc1 loss in young
adult (eight-week old) mice. Tsc1 cHets, and cKOs were treated
with rapamycin or vehicle starting at eight weeks of age, for five
consecutive days (Fig. 8a). A day after the last dose, mice were
assessed for soma size, PV and Kv3.1 expression, and electro-
physiology. To assess rapamycin’s efficacy, we probed for pS6 in
tdTomato+ CINs. Vehicle-treated Tsc1 cKO CINs had increased
co-expression of pS6 compared to the cHet groups and rapa-
mycin treatment significantly reduced these levels (Supplemen-
tary Fig. 12a–e). Notably, rapamycin treatment did not alter the
Fig. 3 SST-Cre-lineage CINs adopt fast-spiking (PV-like) properties after Tsc1 deletion. a Fluorescence (top) and DIC (bottom) images illustrating that
recordings were obtained from tdTomato+/SST+ CINs. Scale bar is 20 µm. b Example voltage traces in response to subthreshold current injections in
WTs (gray), Tsc1 cHets (blue) and Tsc1 cKOs (red). c Comparison of resting membrane potential (RMP), (F2, 67= 0.41, P= 0.66) and input resistance
(Rin), (F2, 67= 6.49, P= 0.002; WT vs. cKO p= 0.001), One-way ANOVA with Tukey’s test. d Example traces in response to suprathreshold current
injections. Traces from two different cells are shown. e Example traces showing action potentials (APs). f Rheobase of SST+ CINs, One-way ANOVA with
Tukey’s test (F2, 67= 5.06, P= 0.009; WT vs. cKO, p= 0.006). g Number of APs fired. Two-way ANOVA with Tukey’s test, Genotype: (F2, 1320= 26.8,
P < 0.0001); WT vs. cHet, and WT vs. cKO, p < 0.0001; cHet vs. cKO, p= 0.008). h Maximum firing frequency of SST+ CINs from WT, cHet and cKO
mice, and PV+ CINs from WT mice (gray triangles) is plotted against the coefficient of variance (CV) of inter-spike interval. Inset, proportion of SST+
CINs with regular-spiking (RS) and fast-spiking (FS) properties. i–m Comparison of AP amplitude (i): (F2, 67= 0.67, P= 0.51), AP threshold (j): (F2, 67=
3.48, P= 0.03; WT vs. cHet p= 0.03), AP max dV/dt (k): (F2, 67= 6.39, P = 0.002; WT vs. cHet p= 0.004, WT vs. cKO p= 0.009), AP half-width (l)
(F2, 67= 11.04, P < 0.0001; WT vs. cHet p= 0.0001, WT vs. cKO p= 0.001); and fAHP amplitude (m): (F2, 67= 5.27, P= 0.007; WT vs. cKO p= 0.005);
One-way ANOVA with Tukey’s test. WT, n= 22 cells, 4 mice; cHet, n= 21 cells, 3 mice; cKO, n= 27 cells, 4 mice; data are presented as mean ± S.E.M.
*p < 0.05; **p < 0.01, ***p < 0.001, ****p < 0.0001. Source data are provided as a Source Data file
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cell density of tdTomato+ CINs or those expressing SST (Sup-
plementary Fig. 12f, g).
Vehicle treated cKO CINs exhibited increased soma size as well
as increased Kv3.1 and PV expression compared to the cHet
groups (Fig. 8b, c, f, g, j–l). Rapamycin treatment significantly
reduced the soma size of SST-lineage CINs in cKOs and
decreased Kv3.1 and PV expression, however, did not alter soma
size or Kv3.1 and PV expression in SST-Cre-lineage cHets
(Fig. 8d, e, h–l). In addition, we assessed whether these cellular
and molecular phenotypes changed after analyzing rapamycin-
treated mice 5 days after discontinuing the drug. While there was
no gross change in soma size 5 days after discontinuing
rapamycin there were increased numbers of Kv3.1+ and PV+
CINs (Supplementary Fig. 13a–c), suggesting that Kv3.1 and PV
expression is dynamic with changes in MTOR activity. Using
a chemogenetic approach, we tested whether PV expression in
SST+ CINs is linked to neuronal excitability. Adult WT SST-Cre
mice expressing either Gq-DREADD-mCherry or mcherry were
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Fig. 4 Increased Kv3.1 channel expression in SST-Cre-lineage CINs underlie FS properties. a P35 coronal sections showing immunofluorescent labeling of
Kv3.1 and tdTomato+ cells from SST-Cre-lineages in the neocortices of WT (i–iii), Tsc1 cHets (iv–vi) and cKOs (vii–ix). Arrows denote co-labeled cells.
Scale bar is 100 µm. b Quantification of the %tdTomato+ cells expressing Kv3.1: Chi-squared test with Yate’s correction, WT vs. cHet, p= 0.02 or cKO,
p < 0.0001, and cHet vs. cKO, p= 0.008, n= 3, all groups (405 WT, 441 cHet and 446 cKO cells counted). c Example firing traces from a model of a layer
5 SST+ CIN with low expression of Kv3.1 (grey) and high expression of Kv3.1 (purple). d, e Firing data from one representative model is shown. Increasing
the conductance of Kv3.1 channel increases the number of APs fired in response to depolarizing current injections (d) and decreases the change in
instantaneous firing frequency during a train of APs (e). Increasing the Kv3.1 conductance in four different models of SST+ CINs increases the maximum
firing frequency: paired two-tailed t-test (t3= 8.1, p= 0.003) (f) and decreases the spike frequency accommodation: SFA; paired two-tailed t-test (t3= 4.9,
p= 0.016) (g). Increasing Kv3.1 conductance in models of SST+ CINs decreases the duration of APs: paired two-tailed t-test (t3= 4.7, p= 0.018) (h) and
increases the fAHP: paired two-tailed t-test (t3= 3.8, p= 0.03) (i). Data are presented as mean ± S.E.M. *p < 0.05, **p < 0.01, ****p < 0.0001. Source data
are provided as a Source Data file
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given daily injections of clozapine-N-oxide (CNO, 3 mg/Kg dose)
for 5 days. Interestingly, Gq-DREADD expressing SST+ CINs
had significantly lower expression of PV in comparison to the
control group (Supplementary Fig. 14). In general, these results
suggest that neuronal excitability and cellular signaling events can
dynamically modulate the molecular programming of CINs.
Next, we tested whether the rapamycin-mediated reduction in
PV expression was accompanied by a reduction in FS
physiological properties within cKO SST-Cre-lineage CINs.
Rapamycin treatment did not change the Rin, firing output or
AP properties of cHet CINs (Fig. 9e, g, h, Supplementary Fig. 14).
However, in the cKO group, rapamycin treatment increased Rin,
reduced the rheobase and increased spike frequency accommoda-
tion (SFA) (Supplementary Fig. 15). Furthermore, rapamycin
reduced the firing output and decreased the fraction of SST-Cre-
lineage CINs that were classified as FS in cKOs (Fig. 9f, i, j).
Notably, even in rapamycin-treated cKO mice, the fraction of FS
SST-Cre-lineage CINs was higher than the fraction of FS SST-Cre-
lineage FS CINs in WT mice (Fig. 3h, inset). Rapamycin-
treatment failed to reverse some effects of Tsc1 loss, including
altered AP properties in cKOs (Supplementary Fig. 15). Overall,
the 5-day rapamycin treatment in adult cKO mice decreased the
aberrant PV expression and partially reversed shifts towards FS
phenotypes in SST-Cre-lineage CINs.
Discussion
Imbalances in neuronal excitation/inhibition (E/I) are implicated
in neuropsychiatric disorders11, and changes in neuronal num-
bers, synaptic connectivity and intrinsic properties of GABAergic
interneurons are, sometimes as a result of compensatory
mechanisms, critical contributors to shifts in E/I balance25,43–46.
TSC-associated neuropsychiatric disorders (TANDs) are com-
mon manifestations of the disorder10 but the mechanisms
underlying TANDs are poorly understood. In this study, we
found that deletion of the TSC causative gene, Tsc1, induced
molecular and physiological changes in CINs that may underlie
some neuropsychiatric symptoms and seizures observed in TSC
(model, supplementary Fig. 16). First, loss of Tsc1 in SST-lineage
CINs altered the programming of PV and Kv3.1 expression and
induced FS properties. This reveals a novel mechanism involved
in regulating the programming of CINs. Second, loss of Tsc1 in
SST-lineages resulted in a neocortex with less synaptic inhibition
onto deep layer pyramidal neurons, which may contribute to the
higher seizure susceptibility observed in TSC. Third, altered
programming could be partially reversed by rapamycin admin-
istration in adulthood, suggesting that these phenotypes remain
plastic in post-mitotic CINs and could provide insights into
potential therapeutic mechanisms to treat TSC.
Previous studies in a mouse model of TSC emphasized that
dysregulation of MTOR signaling primarily affects excitatory
circuits12, and alters E/I balance through effects on excitatory
synapses. While one report examined CINs with regards to
TSC47, little was known about changes in inhibitory circuits. In
this context, we assessed cellular and physiological properties of
CINs and inhibitory synapses in Tsc1 cHets and cKOs. We dis-
covered that loss of Tsc1 in SST-lineages resulted in aberrant
expression of PV and the voltage-gated potassium channel, Kv3.1,
in a subset of SST-lineage CINs. This, in turn, shifts their phy-
siological properties from RS to a continuum encompassing both
RS and FS properties. Notably, not all SST-lineage CINs adopted
these properties, showing that some are less susceptible. This is
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particularly interesting as recent data has shed new light on
subpopulations of SST+ CINs, with distinct molecular identities
and functions48–50.
In contrast to our findings, another group deleted Tsc1 using
the same SST-Cre line and a PV-Cre line but found no physio-
logical phenotypes51, concluding that most TSC phenotypes arise
from excitatory pyramidal neurons. One possibility is that these
disparities could have arisen from each of our groups using dif-
ferent mouse background strains, C57BL/6 vs. CD-1, which could
suggest that some genetic modifiers, i.e. protective and/or
exacerbating, may exist that could be therapeutic targets for TSC.
Moreover, studies into whether distinct cohorts of SST-lineage
CINs are sensitive to MTOR signaling may help elucidate novel
molecular and/or functional properties. Notably, we discovered
that ~20% of WT SST+ CINs have observable pS6 expression
(Supplementary Fig. 1) which may be a distinct susceptible cohort
when Tsc1 is lost. While the phenotypes were milder, Tsc1 cHets
exhibited some of the same changes observed in Tsc1 cKOs.
Finally, TSC1/2 homozygous mutants have been identified in
neural progenitors via a combination of germline and somatic
mutations in a TSC patient52, potentially suggesting that some
phenotypes we observed in Tsc1 cKO mice may also be relevant
to some cases of TSC.
This study suggests new ideas about how some aspects of CIN
cell programming and function are regulated, particularly in post-
mitotic/maturing CINs. Previous studies identified TFs that are
a
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expressed in SST+ CINs but not in PV+ CINs, as well as TFs that
can alter the ratios of SST+ and PV+ CINs22–24,42,53–55. Of note,
the majority of uniquely expressed TFs are found in SST+
CINs56. One hypothesis is that PV+ CIN identity is a default
state of MGE-derived CINs, and is repressed by TFs restricted to
SST-lineages56. Furthermore, perhaps during the maturation of
PV-lineage CINs, MTOR activity is induced to promote PV
expression and FS properties, i.e. when PV expression first
becomes evident during adolescence. This may be achieved as a
consequence of activating certain growth factor receptors or
potentially via synaptic activity7,57 in prospective PV-lineages.
However, given that Tsc1/2 and other components of the MTOR
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pathway are expressed in most cell types, there would need to be
unique factors coupling MTOR signaling in PV-lineages that are
different in SST-lineages. These ideas will be investigated in
future studies.
Most PV+ CINs have FS physiological properties. In contrast,
most SST+ CINs exhibit a RS physiology, although a class of
quasi-fast-spiking SST+ neurons was recently described48.
Moreover, these two neuronal groups are believed to play distinct
and dissociable roles in circuit function58–62. Our data suggest
new possibilities about these classes. First, CINs exhibit inter-
mediate properties after Tsc1 loss, which fall along a continuum
between the classic SST+ and PV+ distinct groups of CINs.
Second, the programming of these classes may be more dynamic
than previously thought. In particular, rapamycin was able to
reverse the expression of PV and FS properties in mature SST-
lineage cKO CINs, suggesting that some aspects of CIN cell
characteristics and programming are malleable by signaling-
dependent plasticity mechanisms that remain to be elucidated.
The extent to which changes in molecular (expression of PV vs.
SST) and physiological (FS vs.RS) properties correlate with
changes in cortical function remains a major question. Differ-
ential expression of ion-channels, like Kv3 channels, underlie the
fast-spiking properties of PV+ CINs20,63. Loss of Tsc1 leads to an
increase in the occurrence of dual identity CINs, which express
both PV and SST. Furthermore, SST-lineage CINs lacking Tsc1
have increased expression of Kv3.1 and the properties of these
CINs are shifted towards a FS physiology. Interestingly, deletion
of FMRP, another monogenic ASD-risk gene, inhibits protein
Fig. 8 Rapamycin decreases PV and Kv3.1 expression in SST-Cre-lineage CINs of cKO mice. a Eight-week old mice that were either SST-Cre; Tsc1 cHets
or cKOs were injected with vehicle or rapamycin consecutively for 5 days and then assessed a day after for soma size, Kv3.1 and PV expression.
b Quantification of tdTomato+ cell soma size: One-way ANOVA (F3, 296= 95.39, P < 0.0001; cKO vs. all groups, cKO veh vs. rapa, and cHet rapa vs. cKO
rapa, p < 0.0001), n= 3 mice per group (25 cells measured from each). (AU) arbitrary units. Immunofluorescent images of the neocortex from vehicle
treated (c, d) and rapamycin treated (e, f) cHet and cKO mice that were co-labeled for tdTomato and Kv3.1. Immunofluorescent images of vehicle treated
(g, h) and rapamycin treated (i, j) cHet and cKO mice co-labeled for tdtomato and PV. Arrows point to co-labeled cells. k Quantification of the cell density
of tdTomato+ cells that co-express Kv3.1: One-way ANOVA (F3, 8= 17.56, P= 0.0007; cKO veh vs. cHet veh, p= 0.0027, cKO veh vs. cHet rapa, p=
0.0007, and cKO veh vs. cKO rapa, p= 0.0035), n= 3 mice per group. l Quantification of the cell density of tdTomato+ cells that co-express PV: One-way
ANOVA (F3, 8= 30.51, P= 0.0001; cKO veh vs. cHet veh and cHet rapa, p= 0.0002 and cKO veh vs. cKO, p= 0.0004), n= 3 mice per group. Data are
presented as mean ± SD in (c) and ± SEM in all other graphs. *p < 0.05, **p < 0.01, ****p < 0.0001. Scale bar j= 100 µm. Source data are provided as a
Source Data file
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Fig. 9 Rapamycin treatment decreases fast-spiking phenotype in SST-Cre lineage CINs in cKO mice. a, b Example voltage traces in response to
suprathreshold current injections in SST+ CINs from vehicle and rapamycin treated cHet (a) and cKO (b) mice. c, d Comparison of firing output: Two-way
ANOVA (F14, 475= 0.63, P= 0.83); and maximum firing frequency: Two-way unpaired t-test (t33= 1.4, p= 0.15) of tdTomato+ CINs in vehicle and
rapamycin treated cHet mice (Vehicle, n= 18 from 2 mice; Rapamycin, n= 17 cells from 2 mice). Inset, pie charts showing the proportion of SST+ CINs
with RS and FS physiological properties in each treatment group. e, f Same as (c, d) for vehicle and rapamycin treated cKO mice. Note the CINs from
rapamycin treated cKO mice have lower firing output: Two-way ANOVA with Bonferroni’s test (F14, 555= 2.86, P= 0.003; 325 pA, p= 0.004 and 350 pA,
p= 0.001), and maximum firing frequency: Two-way unpaired t-test (t37= 2.1, p= 0.04); (Vehicle, n= 19 cells from 2 mice; Rapamycin, n= 20 from 2
mice). Inset, pie charts showing the proportion of SST-lineage CINs with FS and RS physiological properties in each treatment group. Data are presented as
mean ± SEM in all graphs. *p < 0.05, **p < 0.01, ****p < 0.0001. Source data are provided as a Source Data file
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translation downstream of MTOR, of which the Kv3.1 channel is
known to be a target in auditory brain stem neurons64. These
converging findings suggest that modulators of the Kv3.1 channel
could be potential targets for treating cellular and circuit
abnormalities in TSC. Future work will be necessary to under-
stand whether Tsc1 deletion induced shifts in CIN cell pro-
gramming underlie behavioral abnormalities in mutant mice and
humans diagnosed with TSC, which may lead to new therapeutic
targets.
We previously found some overlapping phenotypes after
deletion of Pten in MGE progenitors using Nkx2.1-Cre25. How-
ever, due to a drastic loss in CIN numbers, we were not able to
determine if manipulation of MTOR activity, via Pten loss, spe-
cifically altered CIN programming. Furthermore, Pten deletion
using SST-Cre resulted in no phenotypes, whereas Tsc1 deletion
using SST-Cre did exhibit molecular and physiological pheno-
types without any loss of CINs. These phenotypes allowed us to
gain insights into how MTOR activity influences CIN program-
ming. We do not currently understand why Tsc1 cKOs in
immature SST CINs, but not Pten cKOs, resulted in these phe-
notypes. However, the Tsc genes lie downstream of Pten and at a
crucial point in the signaling pathway inhibiting MTOR signaling.
Moreover, they can be inhibited by other signaling events, i.e.
MAPK signaling. Thus, both their proximity to MTOR in the
signaling cascade and their ability to be inhibited by other sig-
naling moieties may have resulted in differences between the Tsc1
and Pten cKOs.
In summary, we provided evidence that Tsc1-inhibition of
MTOR represses PV+/FS properties in a cohort of SST-Cre-
lineage CINs. Notably, it suggests that regulation of some CIN
molecular and physiological properties can be initiated by non-
transcriptional events, i.e. MTOR signaling. However, whether
transcription is targeted downstream of MTOR signaling is not
yet known. Moreover, we identified specific alterations in
GABAergic CINs and underlying molecular mediators (e.g.,
MTOR and Kv3.1) that could plausibly contribute to neurocog-
nitive symptoms of TSC. Future studies should assess whether
similar abnormalities occur in humans diagnosed with TSC and/
or can be reversed by rapamycin analogs, to more directly
implicate these findings about CINs in the pathogenesis and/or
treatment of TSC.
Methods
Animals. All mouse strains have been published: Ai14 Cre-reporter29, Nkx2.1-
Cre30, PV-Cre37, SST-IRES-Cre28, Tsc1floxed,27,. Tsc1floxed mice were initially on a
mixed C57BL6/J, CD-1 background, then backcrossed to CD-1 for at least four
generations before analysis. For timed pregnancies, noon on the day of the vaginal
plug was counted as embryonic day 0.5. Both male and female mice were assessed.
We did not observe any phenotypic differences between genders and combined all
data for each genotype. All animal care and procedures were performed and
approved according to the Michigan State University and University of California
San Francisco Laboratory Animal Research Center guidelines. We have complied
with all relevant ethical regulations for animal research.
Cell Counting. To determine cell density (cells/mm2), we counted the number of
cells in a given section and then divided by the area of that region. To calculate the
% of tdTomato+ cells that co-labeled with specific markers, we divided the number
of co-labeled cells by the total number of tdTomato+ cells. For cell transplants, all
tdTomato+ cells were counted in the neocortex from all sections in a rostral to
caudal series. For cell fate counts, only transplants where at least 50 tdTomato+
cells could be counted were used for analysis. For soma size quantification, the
perimeter of each tdTomato+ cell’s soma was traced in Image J, and at least 25 cells
were measured and averaged for each mouse.
Acute cortical slice preparation. Adult mice of either sex (P45–P60 days) were
anesthetized with an intraperitonial injection of euthasol and transcardially per-
fused with an ice-cold cutting solution containing (in mM) 210 sucrose, 2.5 KCl,
1.25 NaH2PO4, 25 NaHCO3, 0.5 CaCl2, 7 MgCl2, 7 dextrose (bubbled with 95%
O2–5% CO2, pH ~7.4). Mice were decapitated, the brains were removed and two
parallel cuts were made along the coronal plane at the rostral and caudal ends of
the brains. Brains were mounted on the flat surface created at the caudal end.
Approximately, three coronal slices (250 µm thick) were obtained using Vibrating
blade microtome (VT1200S, Leica Microsystems Inc.). Slices were allowed to
recover at 34 °C for 30 min followed by 30 min recovery at room temperature in a
holding solution containing (in mM) 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25
NaHCO3, 2 CaCl2, 2 MgCl2, 12.5 dextrose, 1.3 ascorbic acid, 3 sodium pyruvate.
Whole-cell patch clamp recordings. Somatic whole-cell current clamp and vol-
tage clamp recordings were obtained from submerged slices perfused in heated
(32–34 °C) artificial cerebrospinal fluid (aCSF) containing (in mM); 125 NaCl, 3
KCl, 1.25 NaH2 PO4, 25 NaHCO3, 2 CaCl2, 1 MgCl2, 12.5 dextrose (bubbled with
95% O2/5% CO2, pH ~7.4). Neurons were visualized using DIC optics fitted with a
40x water-immersion objective (BX51WI, Olympus microscope). Pyramidal neu-
rons and tdtomato expressing CINs located in layer 5 were targeted for patching.
Patch electrodes (2–4MΩ) were pulled from borosilicate capillary glass of external
diameter 1 mm (Sutter Instruments) using a Flaming/Brown micropipette puller
(model P-2000, Sutter Instruments). For current clamp recordings, electrodes were
filled with an internal solution containing the following (in mM): 120 K-gluconate,
20 KCl, 10 HEPES, 4 NaCl, 7 K2-phosphocreatine, 0.3 Na-GTP, and 4 Mg-ATP
(pH ~7.3 adjusted with KOH). Biocytin (Vector Laboratories) was included
(0.1–0.2%) for subsequent histological processing. For voltage clamp recordings,
the internal solution contained the following (in mM): 130 Cs-methanesulfonate,
10 CsCl, 10 HEPES, 4 NaCl, 7 phosphocreatine, 0.3 Na-GTP, 4 Mg-ATP, and 2
QX314-Br (pH ∼7.3 adjusted with CsOH).
Electrophysiology data were recorded using Multiclamp 700B amplifier
(Molecular Devices). Voltages have not been corrected for measured liquid
junction potential (~8 mV). Upon successful transition to the whole-cell
configuration, the neuron was given at least 5 min to stabilize before data were
collected. Series resistance and pipette capacitance were appropriately compensated
before each recording. Series resistance was usually 10–20MΩ, and experiments
were terminated if series resistances exceeded 25MΩ.
Electrophysiology protocols and data analysis. All data analyses were performed
using custom routines written in IGOR Pro (Wavemetrics). Code is available upon
request. Resting membrane potential (RMP) was measured as the membrane
voltage measured in current clamp mode immediately after reaching the whole-cell
configuration. Input resistance (Rin) was calculated as the slope of the linear fit of
the voltage–current plot generated from a family of hyperpolarizing and depolar-
izing current injections (−50 to +20 pA, steps of 10 pA). Firing output was cal-
culated as the number of action potentials (APs) fired in response to 800 ms long
depolarizing current injections (25–500 pA). Firing frequency was calculating as
the number of APs fired per second. Rheobase was measured as the minimum
current injection that elicited spiking. Firing traces in response to 50 pA current
above the rheobase were used for analysis of single AP properties– AP threshold,
maximum dV/dt (rate of rise of AP), AP amplitude, AP half-width and fast after
hyperpolarization (fAHP) amplitude. Threshold was defined as the voltage at
which the value of third derivative of voltage with time is maximum. Action
potential amplitude was measured from threshold to peak, with the half-width
measured at half this distance. Fast after hyperpolarization was measured from the
threshold to the negative voltage peak after the AP. Index of spike-frequency
accommodation (SFA) was calculated as the ratio of the last inter-spike interval to
the first inter-spike interval. Coefficient of variance (CV) for inter-spike interval
(ISI), AP amplitude and AP half-width was calculated as the ratio of standard
deviation to the mean. Recorded CINs in all genotypes were classified as fast-
spiking or regular-spiking based on electrophysiological properties. Specifically,
CINs were classified as fast-spiking if the AP half-width was <0.5 ms, firing fre-
quency >50 Hz, fAHP amplitude was >14 mV and SFA was <2. The correspon-
dence between PV expression and fast-spiking electrophysiological properties was
confirmed in a subset of CINs by quantification of PV staining in biocytin-filled
neurons (16 of 21 biocytin-labeled CINs classified as fast-spiking were PV+).
Spontaneous inhibitory currents were recorded for 5 min with neurons voltage
clamped at +10 mV. Miniature inhibitory currents were recorded in the presence
of TTX. Spontaneous and miniature inhibitory currents were analyzed off-line
using Clampfit (pClamp, Molecular devices) event detection.
For Cre-dependent expression, 600 nl of AAV-DIO-ChR2-eFYP virus was
bilaterally injected into P30–40 SST-Cremice. We waited at least 4 weeks after virus
injection before preparing brain slices. To measure optogenetically evoked
inhibitory currents (oIPSCs), we voltage-clamped layer 5 pyramidal neurons at
+10 mV. We stimulated ChR2 using 5 ms long single or multiple light pulses
(maximum light power, 4 mW/mm2) generated by a Lambda DG-4 high-speed
optical switch with a 300W Xenon lamp (Sutter Instruments) and an excitation
filter centered around 470 nm, delivered to the slice through a ×40 objective
(Olympus). Frequency dependent attenuation (20 Hz) and paired-pulse ratios of
oIPSCs were measured at the maximum light power.
To measure unitary inhibitory currents (uIPSCs), dual whole-cell recordings
were obtained from connected layer 5 tdTomato expressing (SST-Cre lineage or
PV-Cre lineage) CINs and adjacent layer 5 pyramidal neurons. We obtained
current clamp recordings from tdTomato+ CINs and voltage clamp recordings
(+10 mV) from pyramidal neurons. Short duration (1–2 ms) depolarizing current
steps (1–1.5 nA) were injected into the CINs to elicit single action potentials and
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uIPSCs were recorded in postsynaptic pyramidal neurons. Average of 20–30
uIPSCs were used to calculate the peak amplitude (from the baseline to the peak of
uIPSC), rising slope (slope of a fitting line from 10–90% after onset of uIPSC) and
total charge of uIPSCs (integral of uIPSCs from the onset until the trace returned
completely to the baseline).
Computer simulations. Simulations were performed using the NEURON
7.4 simulation environment (Carnevale and Hines, 2006) with Python interface.
Four different morphologically detailed models of SST+ neocortical layer 5 CINs
were used from Allen Brain Atlas; Allen Institute (2015) Documentation, http://
help.brain-map.org/display/celltypes/Documentation. Model files for simulation in
Python environment were downloaded from ModelDB (senselab.med.yale.edu).
Maximum conductance densities (in S/cm2) of Kv3.1 channel (ḡ_kv3.1) were noted
for the four different models (0.25, 0.009, 0.29, 0.56). These values were used for
the low Kv3.1 conductance conditions. To simulate the effects of increase in Kv3.1
expression, ḡ_kv3.1 was increased to 1.5 in all four models. Firing output in the low
and high Kv3.1 conditions were measured as the number of spikes fired in response
to 1 s long depolarizing current steps (50–350 pA). Spike times were measured by
determining the time of AP peak. Instantaneous frequency (1/inter-spike interval)
was computed from current injections that elicited >40 APs. Subthreshold mem-
brane properties were calculated from the voltage traces in response to hyperpo-
larizing and depolarizing current injections (−50 to +20 pA, steps of 10 pA).
Immunofluorescent tissue staining. Immunofluorescent labeling was performed
on 25 µm cryo-sectioned tissue with the following antibodies: mouse anti-Kv3.1b
1:400 (NeuroMab cat. # 75-041); rabbit anti-phosphoS6SER240/244 1:400 (Cell Sig-
naling Technologies cat. # 5364); rabbit anti-PV 1:400 (Swant cat. # PV 27); rat
anti-SST 1:200 (Millipore cat. # MAB354). The appropriate 488, 594 or 647 Alexa-
conjugated secondary antibodies were from Thermo Fisher Scientific (1:300 dilu-
tion). Sections were cover-slipped with Vectashield (Vector labs).
MGE cell transplantation. Lentiviral transduction of MGE cells followed by
intracranial transplantation followed a reported protocol40. Briefly, HEK293T cells
were transfected using Lipofectamine2000 (Thermo Fischer Scientific) with four
plasmids to generate lentivirus particles. E13.5 MGEs from individual embryos
were dissected in ice-cold HBSS and then kept on ice in DMEM media (containing
10% fetal bovine serum). MGEs were then mechanically dissociated with a p1000
pipette tip and transduced with lentivirus. To perform transductions, dissociated
MGE cells were mixed with pre-warmed media that was at physiological pH and
was incubated with ~10–20 μls of concentrated lentivirus, with titers ranging from
1 × 108–1 × 1010 infectious units/ml. They were next incubated at 37 °C for 30 min,
with intervals of agitation. Since the MGE cells had a Cre-dependent reporter,
Ai1429, only MGE cells transduced with Cre-expressing lentiviruses were visible in
the host neocortex after transplantation. This combinatorial method allows the
transduced/transplanted cells to express a strong reporter, i.e. tdTomato expressed
from the beta-actin promoter, while maintaining cell type specificity. Cells were
then pelleted in a tabletop centrifuge at low speed (700 × g, ~4 min) and washed 3
times with media followed by trituration to disperse cells between each wash to
remove excess virus. The final pellet was left under a few μls of media, put on ice,
and the remaining media was removed with a fine point kim wipe before the
injection needle was loaded. For injections, a glass micropipette with a 45° beveled
tip, ~50 μm outer diameter, was preloaded with sterile mineral oil and cells were
then front-loaded into the tip of the needle using a plunger connected to a
hydraulic drive (Narishige MO-10) that was mounted to a stereotaxic frame. Pups
were anesthetized on ice for 1–2 min before being placed on a mold for injections.
Each pup received 3–6 injections of cells, at 70 nl per site, in their right hemisphere.
These sites were about 1 mm apart from rostral to caudal and medial to lateral and
were then injected into layers V-VI of a P1 WT neocortex. After injections, pups
were allowed to recover and then put back with their mother. The transplanted
mice were sacrificed at 35 days post-transplant and transcardially perfused with
PBS followed by 4% PFA. Brains were then post-fixed in 4% PFA for a short
interval, ~30 min, and then sunk in 30% sucrose before embedding in OCT.
DNA vector generation. The DlxI12b-BG-IRES-Cre lentiviral vector backbone is
reported in65. To generate the DlxI12b-BG-hTSC1-IRES-Cre lentiviral vector, the
human TSC1 gene was PCR amplified from a vector containing the hTSC1 cDNA
(Addgene)66. The primers (Forward 5′-GAGAGCTAGCATGGCCCAACAAGCA
AATG-3′ and Reverse 5′-GAGATGTACATTAGCTGTGTTCATGATG-3′), were
used to introduce NheI and BsrGI restriction enzyme sites, respectively (under-
lined). Next the PCR product and the DlxI12b-BG-IRES-Cre vector were digested
with the appropriate enzymes and ligated. The vector was verified by restriction
digest and sequencing.
Rapamycin treatment. Rapamycin (LC Laboratories, Woburn, MA, USA) was
dissolved in ethanol at a concentration of 20 mg/ml and stored at −20 °C. On the
day of the injections, drug was resuspended in saline (containing 0.25% PEG and
0.25% Tween-80). Mice received rapamycin solution (10 mg kg−1) or an equal
volume of vehicle by intraperitoneal injection once daily for 5 consecutive days as
previously described67.
Quantification and statistical analysis. For anatomical analyses, statistics were
performed using Prism version 6, a p-value of <0.05 was considered significant. For
most parametric measurements, we used a One-Way ANOVA with Tukey’s post
test to determine significance (cell density and soma size measurements). For non-
parametric data sets, we used a Chi-squared test with Yate’s correction to deter-
mine significance (data normalized and expressed as a percentage). For electro-
physiological analyses, statistical comparisons were done using custom-written
software in MATLAB or Prism (Graphpad). Statistical significance was assessed
using a paired or unpaired two-tailed Student’s t-test. For repeated observations,
two-way ANOVA followed by a post hoc Tukey’s or Bonferroni’s test was used.
Statistical comparisons across three groups were done using one-way ANOVA
followed by a post hoc Tukey test. Probability values for ANOVAs are denoted as P
and the probability values for post hoc comparisons are denoted as p. Error bars
indicate ± SEM unless otherwise noted.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data used in the analysis of this study are available from the corresponding authors
upon reasonable request. A reporting summary for this article is available as a
Supplementary Information file. The source data for all relevant figures are provided as a
Source Data file.
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